ArticleJournal of clinical and translational hepatology2019

Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C.

Lai Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.